Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03657771 · ClinicalTrials.gov registry record · NA

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

A NA study of Eosinophilic Esophagitis, sponsored by Nemours Children's Clinic.

Completed
Registry status
NA
Development phase
22
Enrollment target
3
Study locations

NCT03657771 is a NA study of Eosinophilic Esophagitis that has completed, run by Nemours Children's Clinic. The registered enrollment target is 22 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03657771, a NA study of Eosinophilic Esophagitis, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
3
Study locations

Study Summary

Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)

Conditions Studied

Interventions

  • OTHER DED
  • OTHER FREE

Study Locations (3)

Delaware

  • Nemours/Alfred I DuPont Hospital for Children - Wilmington

Florida

  • Nemours Children's Hospital - Orlando

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-11-12
Est. Completion 2023-12-31
Phase NA

Sponsor

Nemours Children's Clinic

108 total trials

What the Registry Record Tells You About NCT03657771

The ClinicalTrials.gov registry entry for NCT03657771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (97% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which DED is the first listed.

NCT03657771 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Delaware, Florida, Washington.

Frequently Asked Questions

What is clinical trial NCT03657771 about?

NCT03657771 is a clinical study titled "A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis". Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)

What is the current status of trial NCT03657771?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-11-12. Estimated completion is 2023-12-31.

What conditions does trial NCT03657771 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT03657771?

The interventions under investigation include: DED (OTHER), FREE (OTHER).

Who is sponsoring clinical trial NCT03657771?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03657771 being conducted?

This trial has 3 study locations across Delaware, Florida, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.